Published in Am J Transplant on March 01, 2013
The impact of recipient BKV shedding before transplant on BKV viruria, DNAemia, and nephropathy post-transplant: A prospective study. Pediatr Transplant (2017) 1.40
Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation. Clin Transl Immunology (2014) 0.97
BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12. Am J Transplant (2015) 0.91
Cellular immune therapy for viral infections in transplant patients. Indian J Med Res (2013) 0.86
Efficient uptake of blood-borne BK and JC polyomavirus-like particles in endothelial cells of liver sinusoids and renal vasa recta. PLoS One (2014) 0.83
Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity. Clin Dev Immunol (2013) 0.82
Ureteral Stent Placement Increases the Risk for Developing BK Viremia after Kidney Transplantation. J Transplant (2014) 0.81
What's new in clinical solid organ transplantation by 2013. World J Transplant (2014) 0.81
Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses. Am J Transplant (2016) 0.80
Toward standardization of BK virus monitoring: evaluation of the BK virus R-gene kit for quantification of BK viral load in urine, whole-blood, and plasma specimens. J Clin Microbiol (2014) 0.80
Polyomaviruses and disease: is there more to know than viremia and viruria? Curr Opin Organ Transplant (2015) 0.80
Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodies. J Am Soc Nephrol (2014) 0.80
Brincidofovir (CMX001) inhibits BK polyomavirus replication in primary human urothelial cells. Antimicrob Agents Chemother (2015) 0.79
BK polyomavirus subtype III in a pediatric renal transplant patient with nephropathy. J Clin Microbiol (2013) 0.79
Polyomavirus nephropathy: quantitative urinary polyomavirus-Haufen testing accurately predicts the degree of intrarenal viral disease. Transplantation (2015) 0.79
An Association between BK Virus Replication in Bone Marrow and Cytopenia in Kidney-Transplant Recipients. J Transplant (2014) 0.79
BK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches. Transplantation (2016) 0.78
Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy. Med Microbiol Immunol (2015) 0.78
Specific IgG Antibodies React to Mimotopes of BK Polyomavirus, a Small DNA Tumor Virus, in Healthy Adult Sera. Front Immunol (2017) 0.77
Clinical and pathological features of kidney transplant patients with concurrent polyomavirus nephropathy and rejection-associated endarteritis. World J Transplant (2015) 0.77
Human polyomavirus 9 infection in kidney transplant patients. Emerg Infect Dis (2014) 0.77
Increased Frequency of BK Virus-Specific Polyfunctional CD8+ T Cells Predict Successful Control of BK Viremia After Kidney Transplantation. Transplantation (2016) 0.76
Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation. Clin J Am Soc Nephrol (2014) 0.76
Polyomavirus Reactivation and Immune Responses to Kidney-Specific Self-Antigens in Transplantation. J Am Soc Nephrol (2016) 0.76
Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia. Transpl Infect Dis (2015) 0.76
Review article: BK virus in systemic lupus erythematosus. Pediatr Rheumatol Online J (2015) 0.76
The Noninvasive Urinary Polyomavirus Haufen Test Predicts BK Virus Nephropathy in Children After Hematopoietic Cell Transplantation: A Pilot Study. Transplantation (2016) 0.75
BK viruria and viremia in children with systemic lupus erythematosus. Pediatr Rheumatol Online J (2017) 0.75
Antigen-Specificity of T Cell Infiltrates in Biopsies With T Cell-Mediated Rejection and BK Polyomavirus Viremia: Analysis by Next Generation Sequencing. Am J Transplant (2016) 0.75
The association between polyomavirus BK strains and BKV viruria in liver transplant recipients. Sci Rep (2016) 0.75
BK Virus Load Associated with Serum Levels of sCD30 in Renal Transplant Recipients. Int J Microbiol (2016) 0.75
Imperfect Symmetry of Sp1 and Core Promoter Sequences Regulates Early and Late Virus Gene Expression of the Bidirectional BK Polyomavirus Noncoding Control Region. J Virol (2016) 0.75
Outcomes of renal transplant recipients with BK virus infection and BK virus surveillance in the Auckland region from 2006 to 2012. World J Nephrol (2016) 0.75
BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection. World J Transplant (2016) 0.75
Limited Variation in BK Virus T-Cell Epitopes Revealed by Next-Generation Sequencing. J Clin Microbiol (2015) 0.75
Evaluation of leflunomide for the treatment of BK viremia and biopsy proven BK nephropathy; a single center experience. J Nephropathol (2015) 0.75
Intragraft Antiviral-Specific Gene Expression as a Distinctive Transcriptional Signature for Studies in Polyomavirus-Associated Nephropathy. Transplantation (2016) 0.75
Optimal use of plasma and urine BK viral loads for screening and predicting BK nephropathy. BMC Infect Dis (2016) 0.75
Polyomavirus-Specific Cellular Immunity: From BK-Virus-Specific Cellular Immunity to BK-Virus-Associated Nephropathy? Front Immunol (2015) 0.75
Polyclonal gammopathy after BKV infection in HSCT recipient: a novel trigger for plasma cells replication? Virol J (2015) 0.75
High-level viruria as a screening tool for BK virus nephropathy in renal transplant recipients. Kidney Res Clin Pract (2016) 0.75
Calibration of BK Virus Nucleic Acid Amplification Testing to the 1st WHO International Standard for BK Virus. J Clin Microbiol (2017) 0.75
Factors Influencing Graft Outcomes Following Diagnosis of Polyomavirus -Associated Nephropathy after Renal Transplantation. PLoS One (2015) 0.75
BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies. Clin Microbiol Rev (2017) 0.75
Intragraft Blood Dendritic Cell Antigen-1-Positive Myeloid Dendritic Cells Increase during BK Polyomavirus-Associated Nephropathy. J Am Soc Nephrol (2015) 0.75
A delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipients. PLoS One (2017) 0.75
IL28B rs12979860 genotype as a predictor marker of progression to BKVirus Associated nephropathy, after kidney transplantation. Sci Rep (2017) 0.75
The Case for Laboratory Developed Procedures: Quality and Positive Impact on Patient Care. Acad Pathol (2017) 0.75
Pre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients. PLoS One (2017) 0.75
Kidney retransplantation in children following rejection and recurrent disease. Pediatr Nephrol (2016) 0.75
Outcome in Pancreas Grafts After BK Virus Viremia in Simultaneous Pancreas-Kidney Transplants: A Single-Center Case Report. Transplant Direct (2017) 0.75
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant (2006) 2.48
A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant (2010) 2.14
A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation (1995) 2.09
Experience with liver and kidney allografts from non-heart-beating donors. Transplantation (1995) 1.83
Cytomegalovirus in solid organ transplant recipients. Am J Transplant (2009) 1.74
"Plasma cell hepatitis" in liver allografts: identification and characterization of an IgG4-rich cohort. Am J Transplant (2013) 1.52
An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant (2001) 1.48
Cytomegalovirus in solid organ transplantation. Am J Transplant (2013) 1.48
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology (2000) 1.44
Pulmonary blastoma. An immunohistochemical analysis with comparison with fetal lung in its pseudoglandular stage. Am J Clin Pathol (1990) 1.41
FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc (1991) 1.37
BK virus in solid organ transplant recipients. Am J Transplant (2009) 1.32
Pneumocystis pneumonia in solid organ transplantation. Am J Transplant (2013) 1.30
BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis (1995) 1.28
Development and experience with an integrated system for transplantation telepathology. Hum Pathol (2001) 1.23
Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant (2009) 1.20
Invasive aspergillosis in solid organ transplant recipients. Am J Transplant (2009) 1.18
A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy. Clin Transplant (1994) 1.15
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation (1999) 1.14
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc (1995) 1.13
Tacrolimus in renal transplantation. Transplant Proc (1996) 1.10
Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant (2009) 1.09
Molecular genotyping of BK and JC viruses in human polyomavirus-associated interstitial nephritis after renal transplantation. Am J Kidney Dis (2001) 1.07
Ventricular assist device related infections and solid organ transplantation. Am J Transplant (2013) 1.05
Candida in solid organ transplant recipients. Am J Transplant (2009) 1.05
Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel. Am J Transplant (2008) 1.05
Nocardia in solid organ transplant recipients. Am J Transplant (2009) 1.04
Aspergillosis in solid organ transplantation. Am J Transplant (2013) 1.02
Varicella zoster virus (VZV) in solid organ transplant recipients. Am J Transplant (2009) 1.02
Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation. Am J Transplant (2013) 1.00
Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol (1989) 0.99
Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up. Am J Transplant (2008) 0.98
Epstein-barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients. Am J Transplant (2009) 0.98
Influenza vaccination in the organ transplant recipient: review and summary recommendations. Am J Transplant (2011) 0.98
Vaccination in solid organ transplantation. Am J Transplant (2013) 0.96
Donor-derived infections in solid organ transplantation. Am J Transplant (2013) 0.96
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation (1999) 0.96
Tacrolimus rescue therapy for renal allograft rejection--five-year experience. Transplantation (1997) 0.95
Pneumocystis pneumonia in solid organ transplant recipients. Am J Transplant (2009) 0.95
Solid organ transplantation in the HIV-infected patient. Am J Transplant (2009) 0.94
RNA respiratory viral infections in solid organ transplant recipients. Am J Transplant (2009) 0.93
Cryptococcosis in solid organ transplant recipients. Am J Transplant (2009) 0.93
Mycobacterium tuberculosis infections in solid organ transplantation. Am J Transplant (2013) 0.93
Adenovirus in solid organ transplant recipients. Am J Transplant (2009) 0.91
Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-updated Banff grading schema. Am J Transplant (2011) 0.91
The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome. Am J Transplant (2012) 0.91
Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation (2002) 0.91
Introduction: infection in solid organ transplant recipients. Am J Transplant (2009) 0.91
Clostridium difficile infections in solid organ transplantation. Am J Transplant (2013) 0.91
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc (1998) 0.91
Renal allograft rejection with normal renal function in simultaneous kidney/pancreas recipients: does dissynchronous rejection really exist? Transplantation (2000) 0.91
Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol (2004) 0.91
Adenovirus in solid organ transplantation. Am J Transplant (2013) 0.90
European perspective on human polyomavirus infection, replication and disease in solid organ transplantation. Clin Microbiol Infect (2014) 0.90
Screening of donor and recipient in solid organ transplantation. Am J Transplant (2013) 0.90
Parasitic infections in solid organ transplantation. Am J Transplant (2013) 0.90
Human immunodeficiency virus in solid organ transplantation. Am J Transplant (2013) 0.89
Multidrug-resistant gram-negative bacteria infections in solid organ transplantation. Am J Transplant (2013) 0.89
Urinary tract infections in solid organ transplantation. Am J Transplant (2013) 0.88
Re-examination of the lymphocytotoxic crossmatch in liver transplantation: can C4d stains help in monitoring? Am J Transplant (2011) 0.88
Cryptococcosis in solid organ transplantation. Am J Transplant (2013) 0.88
Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation. Transplant Proc (2005) 0.88
Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients. Transplantation (2001) 0.88
Multidrug resistant gram-negative bacteria in solid organ transplant recipients. Am J Transplant (2009) 0.87
Parvovirus B19 in solid organ transplant recipients. Am J Transplant (2009) 0.86
Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients. Hum Pathol (1996) 0.85
Methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus infections in solid organ transplantation. Am J Transplant (2013) 0.85
Banff Initiative for Quality Assurance in Transplantation (BIFQUIT): reproducibility of polyomavirus immunohistochemistry in kidney allografts. Am J Transplant (2014) 0.84
Strategies for safe living following solid organ transplantation. Am J Transplant (2009) 0.83
Candida infections in solid organ transplantation. Am J Transplant (2013) 0.83
Viral hepatitis in solid organ transplant recipients. Am J Transplant (2009) 0.83
HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am J Transplant (2009) 0.83
Arcuate and interlobular phlebitis in renal allografts. Hum Pathol (2001) 0.83
Banff initiative for quality assurance in transplantation (BIFQUIT): reproducibility of C4d immunohistochemistry in kidney allografts. Am J Transplant (2013) 0.82
Renal transplantation in recipients over the age of 60: the impact of donor age. Transplantation (1999) 0.82
Emerging & rare fungal infections in solid organ transplant recipients. Am J Transplant (2009) 0.82
Parasitic infections in solid organ transplant recipients. Am J Transplant (2009) 0.82
Varicella zoster virus in solid organ transplantation. Am J Transplant (2013) 0.82
Plasma FK506 levels in patients with histopathologically documented renal allograft rejection. Transplantation (1994) 0.82
Biologic diversity of polyomavirus BK genomic sequences: Implications for molecular diagnostic laboratories. J Med Virol (2008) 0.82
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. Transplantation (1996) 0.82
Human herpesvirus 6, 7 and 8 in solid organ transplantation. Am J Transplant (2013) 0.81
1.7 year follow-up after bortezomib therapy for refractory antibody mediated rejection. Clin Transpl (2010) 0.81
HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am J Transplant (2009) 0.81
Tacrolimus for rescue of refractory renal allograft rejection. Transplant Proc (1998) 0.81
Herpes simplex virus infections in solid organ transplant recipients. Am J Transplant (2009) 0.80
Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient. Cancer (1993) 0.80
Clostridium difficile in solid organ transplant recipients. Am J Transplant (2009) 0.80
Nocardia infections in solid organ transplantation. Am J Transplant (2013) 0.80
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant (1997) 0.79
Urinary tract infections in solid organ transplant recipients. Am J Transplant (2009) 0.79
HLA susceptibility to BKV infection. Am J Transplant (2006) 0.79
Travel medicine and transplant tourism in solid organ transplantation. Am J Transplant (2013) 0.79
Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection. Transplant Proc (1997) 0.79
Interactions between anti-infective agents and immunosuppressants in solid organ transplantation. Am J Transplant (2013) 0.79